Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00599118 · ClinicalTrials.gov registry record
Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation
A clinical trial of Atrial Fibrillation, sponsored by The Cleveland Clinic.
- Active
- Registry status
- 1,300
- Enrollment target
- 1
- Study location
NCT00599118 is a study of Atrial Fibrillation that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 1,300 participants, below the 2,990-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00599118, a study of Atrial Fibrillation, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 1,300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to establish a genebank repository of blood samples and data to generate information about the hereditary (genetic) basis of atrial fibrillation.
Conditions Studied
Study Locations (1)
Ohio
- Cleveland Clinical Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,300 participants |
| Start Date | 2005-08 |
| Est. Completion | 2035-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00599118
The ClinicalTrials.gov registry entry for NCT00599118 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,990-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (57% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 0 interventions.
NCT00599118 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00599118 about?
NCT00599118 is a clinical study titled "Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation". The purpose of this study is to establish a genebank repository of blood samples and data to generate information about the hereditary (genetic) basis of atrial fibrillation.
What is the current status of trial NCT00599118?
This trial is currently active not recruiting. The enrollment target is 1,300 participants. The study started on 2005-08. Estimated completion is 2035-12.
What conditions does trial NCT00599118 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
Who is sponsoring clinical trial NCT00599118?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00599118 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.